Promise Tracker
0 delivered, 0 close, 1 missed.
View Promises →Fairchem Organics reported Q4 FY26 revenue of ₹117 crore, down 3.2% YoY, but EBITDA margin improved sharply to 6.9% (up 320 bps YoY) driven by better price realization as Chinese dumping eased.
Financial stats pending filing verification
Fairchem Organics reported Q4 FY26 revenue of ₹117 crore, down 3.2% YoY, but EBITDA margin improved sharply to 6.9% (up 320 bps YoY) driven by better price realization as Chinese dumping eased. PAT stood at ₹3.7 crore. Full-year revenue was ₹460 crore, down 14.5% YoY, with volume declining to 44,000 tons from 54,000 tons. Management expects FY27 capacity utilization to reach 75-80% (from ~55% in FY26) and EBITDA margins to breach 8%, aided by reduced Chinese competition, energy cost savings, and a recovering paint industry. Exports are targeted to rise from 9% to 20% of sales. A new 40,000-ton specialty chemical plant (novel process) is expected to contribute meaningfully in 2-3 years. Key risk: Chinese dumping could resume if export incentives are reinstated.
0 delivered, 0 close, 1 missed.
View Promises →Resumption of Chinese dumping
View Risks →Full transcript text is available on this route.
Read Transcript →Volume declined from 54,000 tons in FY25 due to deliberate production cuts amid adverse pricing.
Utilization dropped from ~79% in FY25; management targets 75-80% in FY27.
Exports remained at 8-9% of revenue; target is 20% in FY27.
Dimer acid contributed ~30% of total revenue; isostearic acid contributed ₹26 crore (~6%).
Management expects EBITDA margin to exceed 8% in FY27, driven by higher capacity utilization, reduced Chinese dumping, and energy cost savings.
Targeting 75-80% utilization of 80,000-ton capacity, up from ~55% in FY26, as demand recovers and Chinese competition eases.
Exports expected to rise from 9% to 20% of revenue, driven by US, Europe, and Japan markets, aided by tariff reductions and rupee depreciation.
A 40,000-ton novel process plant will be commissioned in Q2 FY27; revenue contribution expected after 2-2.5 years due to customer validation.
Management expects volume and value growth to begin in H2 FY27, with better numbers visible from that period.
All volume growth will come from existing capacity (55% utilization); no significant capex required.
The animal feed plant is ready; production will start after GMP certification. Initial small capacity, expand later.
A new product (name undisclosed) is expected to go into production by Q3 FY27, using existing capacity.
Chinese exporters could restart aggressive pricing if export incentives are reinstated, pressuring realizations and margins.
The new specialty chemical plant requires 2-2.5 years for customer validation, delaying revenue contribution and margin expansion.
Ongoing Middle East crisis could disrupt global supply chains and commodity prices, affecting input costs and export competitiveness.
Chinese suppliers benefit from export incentives (~13%) and lower import duty (7.5% vs 16.5% on raw materials), pressuring margins.
Lower uptake from paint segment due to market share disruption from new entrants; no major recovery seen yet.
Recovery hinges on US/UK/EU trade deals; any delay or unfavorable terms could prolong export weakness.
Management expects EBITDA margin to exceed 8% in FY27, driven by higher capacity utilization, reduced Chinese dumping, and energy cost savings.
Chinese exporters could restart aggressive pricing if export incentives are reinstated, pressuring realizations and margins.
View Risks →